Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 580

1.

Vanishing midbrain mass lesion - A germinoma?

Purkart TU, Seifert-Held T, Haybäck J, Holl E, Asslaber M, Payer F, Fazekas F.

J Neurol Sci. 2019 Jun 13;404:40-43. doi: 10.1016/j.jns.2019.06.013. [Epub ahead of print] No abstract available.

PMID:
31325666
2.

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum in: Lancet Diabetes Endocrinol. 2019 Jul 8;:.

PMID:
31272931
3.

Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.

Kneihsl M, Gattringer T, Bisping E, Scherr D, Raggam R, Mangge H, Enzinger C, Fandler-Höfler S, Eppinger S, Hermetter C, Bucnik B, Poltrum B, Niederkorn K, Fazekas F.

Stroke. 2019 Aug;50(8):2223-2226. doi: 10.1161/STROKEAHA.119.025339. Epub 2019 Jun 20.

PMID:
31216968
4.

Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries.

Aguiar de Sousa D, von Martial R, Abilleira S, Gattringer T, Kobayashi A, Gallofré M, Fazekas F, Szikora I, Feigin V, Caso V, Fischer U.

Eur Stroke J. 2019 Mar;4(1):13-28. doi: 10.1177/2396987318786023. Epub 2018 Jul 20.

5.

Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.

Wilson D, Ambler G, Lee KJ, Lim JS, Shiozawa M, Koga M, Li L, Lovelock C, Chabriat H, Hennerici M, Wong YK, Mak HKF, Prats-Sánchez L, Martínez-Domeño A, Inamura S, Yoshifuji K, Arsava EM, Horstmann S, Purrucker J, Lam BYK, Wong A, Kim YD, Song TJ, Schrooten M, Lemmens R, Eppinger S, Gattringer T, Uysal E, Tanriverdi Z, Bornstein NM, Assayag EB, Hallevi H, Tanaka J, Hara H, Coutts SB, Hert L, Polymeris A, Seiffge DJ, Lyrer P, Algra A, Kappelle J, Al-Shahi Salman R, Jäger HR, Lip GYH, Mattle HP, Panos LD, Mas JL, Legrand L, Karayiannis C, Phan T, Gunkel S, Christ N, Abrigo J, Leung T, Chu W, Chappell F, Makin S, Hayden D, Williams DJ, Kooi ME, van Dam-Nolen DHK, Barbato C, Browning S, Wiegertjes K, Tuladhar AM, Maaijwee N, Guevarra C, Yatawara C, Mendyk AM, Delmaire C, Köhler S, van Oostenbrugge R, Zhou Y, Xu C, Hilal S, Gyanwali B, Chen C, Lou M, Staals J, Bordet R, Kandiah N, de Leeuw FE, Simister R, van der Lugt A, Kelly PJ, Wardlaw JM, Soo Y, Fluri F, Srikanth V, Calvet D, Jung S, Kwa VIH, Engelter ST, Peters N, Smith EE, Yakushiji Y, Orken DN, Fazekas F, Thijs V, Heo JH, Mok V, Veltkamp R, Ay H, Imaizumi T, Gomez-Anson B, Lau KK, Jouvent E, Rothwell PM, Toyoda K, Bae HJ, Marti-Fabregas J, Werring DJ; Microbleeds International Collaborative Network.

Lancet Neurol. 2019 Jul;18(7):653-665. doi: 10.1016/S1474-4422(19)30197-8. Epub 2019 May 23. Erratum in: Lancet Neurol. 2019 Jul 12;:.

6.

Commentary on 'Spontaneous multiple cervical artery dissections after alemtuzumab'.

Pichler A, Fazekas F.

Mult Scler. 2019 May 9:1352458519845110. doi: 10.1177/1352458519845110. [Epub ahead of print] No abstract available.

PMID:
31070515
7.

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Leurs CE, Twaalfhoven H, Lissenberg-Witte BI, van Pesch V, Dujmovic I, Drulovic J, Castellazzi M, Bellini T, Pugliatti M, Kuhle J, Villar LM, Alvarez-Cermeño JC, Alvarez-Lafuente R, Hegen H, Deisenhammer F, Walchhofer LM, Thouvenot E, Comabella M, Montalban X, Vécsei L, Rajda C, Galimberti D, Scarpini E, Altintas A, Rejdak K, Frederiksen JL, Pihl-Jensen G, Jensen P, Khalil M, Voortman MM, Fazekas F, Saiz A, La Puma D, Vercammen M, Vanopdenbosch L, Uitdehaag B, Killestein J, Bridel C, Teunissen C.

Mult Scler. 2019 May 8:1352458519845844. doi: 10.1177/1352458519845844. [Epub ahead of print]

PMID:
31066634
8.

Are morphologic features of recent small subcortical infarcts related to specific etiologic aspects?

Eppinger S, Gattringer T, Nachbaur L, Fandler S, Pirpamer L, Ropele S, Wardlaw J, Enzinger C, Fazekas F.

Ther Adv Neurol Disord. 2019 Apr 22;12:1756286419835716. doi: 10.1177/1756286419835716. eCollection 2019.

9.

Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations.

Thrippleton MJ, Backes WH, Sourbron S, Ingrisch M, van Osch MJP, Dichgans M, Fazekas F, Ropele S, Frayne R, van Oostenbrugge RJ, Smith EE, Wardlaw JM.

Alzheimers Dement. 2019 Jun;15(6):840-858. doi: 10.1016/j.jalz.2019.01.013. Epub 2019 Apr 25. Review.

10.

Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.

Komajda M, Schöpe J, Wagenpfeil S, Tavazzi L, Böhm M, Ponikowski P, Anker SD, Filippatos GS, Cowie MR; QUALIFY Investigators.

Eur J Heart Fail. 2019 Apr 1. doi: 10.1002/ejhf.1459. [Epub ahead of print]

PMID:
30933403
11.

Postural hemodynamic parameters in older persons have a seasonal dependency : A pilot study.

Trozic I, Platzer D, Fazekas F, Bondarenko AI, Brix B, Rössler A, Goswami N.

Z Gerontol Geriatr. 2019 Mar 13. doi: 10.1007/s00391-019-01525-3. [Epub ahead of print]

PMID:
30868225
12.

White Matter Hyperintensities in Alzheimer's Disease: A Lesion Probability Mapping Study.

Damulina A, Pirpamer L, Seiler S, Benke T, Dal-Bianco P, Ransmayr G, Struhal W, Hofer E, Langkammer C, Duering M, Fazekas F, Schmidt R.

J Alzheimers Dis. 2019;68(2):789-796. doi: 10.3233/JAD-180982.

PMID:
30775995
13.

Magnetic resonance elastography of the human brain using a multiphase DENSE acquisition.

Strasser J, Haindl MT, Stollberger R, Fazekas F, Ropele S.

Magn Reson Med. 2019 Jun;81(6):3578-3587. doi: 10.1002/mrm.27672. Epub 2019 Jan 29.

14.

Quantitative Susceptibility Mapping to Assess Cerebral Vascular Compliance.

Birkl C, Langkammer C, Sati P, Enzinger C, Fazekas F, Ropele S.

AJNR Am J Neuroradiol. 2019 Mar;40(3):460-463. doi: 10.3174/ajnr.A5933. Epub 2019 Jan 24.

PMID:
30679209
15.

Association between pathological and MRI findings in multiple sclerosis.

Filippi M, Brück W, Chard D, Fazekas F, Geurts JJG, Enzinger C, Hametner S, Kuhlmann T, Preziosa P, Rovira À, Schmierer K, Stadelmann C, Rocca MA; Attendees of the Correlation between Pathological and MRI findings in MS workshop.

Lancet Neurol. 2019 Feb;18(2):198-210. doi: 10.1016/S1474-4422(18)30451-4. Review.

PMID:
30663609
16.

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders.

Ciccarelli O, Cohen JA, Reingold SC, Weinshenker BG; International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.

Lancet Neurol. 2019 Feb;18(2):185-197. doi: 10.1016/S1474-4422(18)30460-5. Review.

PMID:
30663608
17.

Diagnostic accuracy of noncontrast CT imaging markers in cerebral venous thrombosis.

Buyck PJ, Zuurbier SM, Garcia-Esperon C, Barboza MA, Costa P, Escudero I, Renard D, Lemmens R, Hinteregger N, Fazekas F, Conde JJ, Giralt-Steinhauer E, Hiltunen S, Arauz A, Pezzini A, Montaner J, Putaala J, Weimar C, Churilov L, Gattringer T, Asadi H, Tatlisumak T, Coutinho JM, Demaerel P, Thijs V.

Neurology. 2019 Feb 19;92(8):e841-e851. doi: 10.1212/WNL.0000000000006959. Epub 2019 Jan 18.

PMID:
30659138
18.

Instead of tweaking the diagnostic criteria for MS in those with CIS, we should develop diagnostic criteria that distinguish MS from other conditions - Commentary.

Fazekas F.

Mult Scler. 2019 May;25(6):770-771. doi: 10.1177/1352458518820700. Epub 2019 Jan 11. No abstract available.

PMID:
30632449
19.

Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis.

Chatterjee M, Koel-Simmelink MJ, Verberk IM, Killestein J, Vrenken H, Enzinger C, Ropele S, Fazekas F, Khalil M, Teunissen CE.

Mult Scler J Exp Transl Clin. 2018 Dec 24;4(4):2055217318819535. doi: 10.1177/2055217318819535. eCollection 2018 Oct-Dec.

20.

Predicting Early Mortality of Acute Ischemic Stroke.

Gattringer T, Posekany A, Niederkorn K, Knoflach M, Poltrum B, Mutzenbach S, Haring HP, Ferrari J, Lang W, Willeit J, Kiechl S, Enzinger C, Fazekas F; Austrian Stroke Unit Registry Collaborators.

Stroke. 2019 Feb;50(2):349-356. doi: 10.1161/STROKEAHA.118.022863.

PMID:
30580732

Supplemental Content

Loading ...
Support Center